FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

375611000001109: Metenix 5 tablets (Borg Medicare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16414301000001116 Metenix 5 tablets (Borg Medicare Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65935801000001112 Metenix 5mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Metenix 5 tablets (Borg Medicare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Is a Product containing precisely metolazone 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Has active ingredient Metolazone false Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Is a Metenix true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Has specific active ingredient Metolazone true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Metenix 5 tablets (Borg Medicare Ltd) 100 tablet 10 x 10 tablets Is pack of False Metenix 5 tablets (Borg Medicare Ltd) Inferred relationship Existential restriction modifier
Metenix 5 tablets (Borg Medicare Ltd) 100 tablet 10 x 10 tablets Has AMP True Metenix 5 tablets (Borg Medicare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start